GUNSHOT INJURIES TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Gunshot Injuries Treatment Market Size and Share Analysis - 2026 To 2033

The global gunshot injuries treatment market size is projected to grow from USD 16.3 Mn in 2026 to USD 28.2 Mn by 2033, registering a compound annual growth rate (CAGR) of 8.2% during the forecast period (2026-2033). This growth is mostly due to the increasing incidence of firearm-related injuries, rising demand for advanced trauma care and emergency medical services, growing healthcare infrastructure investments, and continuous advancements in surgical treatment and wound management technologies.

Key Takeaways from the Gunshot Injuries Treatment Market Report

• XStat segment is expected to lead the market with a share of 46% in 2026 owing to its increasing adoption in military combat care, emergency trauma response, and rapid hemorrhage control applications. According to the Centers for Disease Control and Prevention, more than 48,000 firearm-related deaths were reported in the U.S. in recent years, highlighting the growing need for advanced bleeding control technologies in emergency care.
• North America is projected to lead the global market by 2026, holding approximately 43% of the total market share owing to the high prevalence of gunshot injuries, well-developed infrastructure for trauma care, and extensive use of emergency bleeding control systems. As per the statistics released by the CDC, the number of firearm-related injuries and fatalities in the US runs into tens of thousands each year.

Rising Incidence of Firearm-Related Injuries is Driving Growth in the Gunshot Injuries Treatment Market

The rising incidence of firearm-related injuries and trauma cases worldwide is increasing demand for advanced gunshot injury treatment solutions. There is a growing trend of hospitals, military medical facilities, and emergency medical services opting for bleeding control technologies, trauma bandages, and surgical hemostasis products to enhance chances of survival in emergencies.

Moreover, the World Health Organization indicates that about 4.4 million people die from injuries each year all over the world. This highlights the need for trauma care systems and bleeding control products used during surgeries.

Advancements in Hemorrhage Control Technologies are Transforming Emergency Trauma Care

Technological developments in the fields of hemorrhage management and trauma care have greatly improved the effectiveness of treatments for victims of gunshots. Advanced technologies like expandable sponge bandages, coagulating matrices, and fast coagulant gels help doctors better manage patient situations both in emergencies and surgeries. The increasing use of these technologies in military combat medicine, ambulance operations, and civilian trauma clinics can be attributed to their efficiency in reducing blood loss and saving lives.

According to the U.S. Food and Drug Administration, several advanced hemostatic and wound treatment technologies have received regulatory approvals in recent years to support emergency trauma care and surgical bleeding management applications.

Current Events and Their Impact on the Gunshot Injuries Treatment Market

Segmental Insights 

Why is XStat Acquiring the Largest Market Share?

XStat is expected to capture the largest market share by 2026 in the gunshot wounds treatment market, contributing about 46% of the total market size. This is due to the rise in the use of hemostasis techniques in military combat medicine, trauma, and bleeding management applications globally.

In January 2026, the Naval Medical Research Command announced that the XSTAT P15 wound treatment device received FDA 510(k) clearance in partnership with RevMedx. The advanced hemorrhage control device was specifically developed for treating narrow-entry gunshot and shrapnel wounds in combat and emergency environments.

Gunshot Injuries Treatment Market Trends

• Increased use of sophisticated technologies like hemostatic dressings, hemostatic agents, and trauma dressings for treating bleeding has increased survival rates in trauma cases and military injuries.
• High investment in military healthcare technology and battlefield injury management technology has increased the demand for portable gunshot wound treatment devices across the globe.
• The increasing integration of fast-reaction EMS and trauma care facilities is driving the adoption of bleeding control devices within hospitals and ambulances.
• Technological developments in surgical hemostatic and wound treatment products are enhancing the efficacy of treatments and minimizing blood loss in surgical procedures. These products include XStat and Floseal, which are gaining more popularity within the military and emergency medicine industry.
• The growing global trauma burden will drive market growth. The World Health Organization states that trauma contributes to around 4.4 million fatalities each year worldwide, thus adding to the significance of the development of high-end trauma treatment systems and hemostasis devices.

Regional Insights 

North America Dominates the Gunshot Injuries Treatment Market Owing to Advanced Trauma Care Infrastructure

North America is estimated to contribute around 43% towards the global market share of gunshot injuries treatment by 2026 owing to the prevalence of firearm injuries, well-established trauma facilities, and adoption of hemorrhage control devices in this region. North America is marked by robust health care expenditures, mature emergency response mechanisms, and growing adoption of advanced wound care products.

Technological innovations are contributing towards regional market growth. Firms in trauma care and hemorrhage management are introducing highly sophisticated battlefield and emergency response products for improving survival rates. The growing number of military modernization programs and increasing spending on emergency management systems are also driving market growth in the United States and Canada.

In January 2026, the Naval Medical Research Command announced FDA 510(k) clearance for the XSTAT P15 device developed with RevMedx.

Asia Pacific Gunshot Injuries Treatment Market Trends

Asia Pacific is expected to emerge as the region with the fastest growth rate between 2026 and 2033 owing to the development of healthcare infrastructures, emergency trauma treatment facilities, and technological advancements in wound management technology, especially in countries like China, India, and Japan.

The region is witnessing rapid expansion of trauma centers and emergency medical response systems. Urbanization, vehicular accidents, and emergencies requiring surgery and bleeding control products have led to increased product demand.

According to the World Health Organization, injuries account for nearly 4.4 million deaths globally every year, increasing the importance of emergency trauma treatment systems across developing economies in Asia Pacific.

U.S. Gunshot Injuries Treatment Market Trends

The gunshot injuries treatment market in the U.S. is projected to grow at a stable pace in the forecast period. The growth is primarily attributed to the rise in the number of gun injuries, increased investments in trauma centers, rising adoption of innovative hemorrhage control solutions, and robust government expenditure on military healthcare services.

According to the CDC, there are more cases of non-fatal gunshot wounds than fatalities, and over 70% of medically attended gunshot wounds are due to assaults. The figures are expected to fuel the demand for innovative hemorrhage control technology,

China Gunshot Injuries Treatment Market Forecast

China is anticipated to become an emerging market for gunshot injuries treatment technology solutions over the forecast period. Factors driving market growth include increased healthcare infrastructure development, improved emergency trauma response networks, increased utilization of surgical wound care products, and enhanced government preparedness programs.

Modernization of trauma centers and emergency medical care services is becoming a significant growth factor in China. Increased investments in hospitals' infrastructure and equipment have increased the availability of trauma treatment devices such as surgical agents for controlling hemorrhages and bleeding.

In February 2025, MicroPort Official Website announced that its Firelimus Drug-Coated Balloon Catheter received NMPA market approval in China.

Who are the Major Companies in Gunshot Injuries Treatment Industry

Some of the major key players in Gunshot Injuries Treatment are RevMedx, Inc., Baxter International Inc., Medtrade Products Ltd., Stryker Corporation, Johnson & Johnson MedTech, 3M Health Care, Teleflex Incorporated, Smith & Nephew, B. Braun SE, and Zhejiang Haichuang Medical Device Co., Ltd.

Industry News

• In January 2026, RevMedx announced that the XSTAT P15 wound treatment device received FDA 510(k) clearance for treating severe bleeding caused by gunshot and shrapnel wounds in combat and emergency trauma environments.
• In April 2025, Teleflex Incorporated announced that the QuikClot Control+ Hemostatic Device received expanded FDA clearance for managing all grades of internal and external bleeding during trauma and emergency procedures.
• In May 2025, Smith & Nephew announced expanded deployment of its RENASYS TOUCH Negative Pressure Wound Therapy systems for military trauma and wound care applications in collaboration with U.S. defense healthcare programs.

Market Report Scope 

Analyst Opinion

• The gunshot injuries treatment market is primarily driven by the increasing global burden of firearm-related injuries and trauma cases.
• Demand for rapid bleeding control technologies continues to rise as hemorrhage remains one of the leading causes of preventable trauma deaths. Advanced products such as injectable wound sponges, hemostatic dressings, and portable trauma devices are increasingly becoming essential components of military and civilian emergency response systems.
• Military modernization programs and emergency preparedness initiatives are significantly accelerating adoption of battlefield trauma technologies. Increasing investments in combat casualty care, portable wound management systems, and emergency surgical treatment solutions are expected to create strong long-term growth opportunities for manufacturers operating in the gunshot injuries treatment market.

Market Segmentation

• By Product (Revenue, USD Mn, 2021-2033)
  • XStat
  • Airwrap
  • Floseal
• By Region (Revenue, USD Mn, 2021-2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Central Africa
    • North Africa

Sources

Primary Research Interviews

• Trauma surgeons
• Emergency medicine physicians
• Military combat medical professionals
• Hospital administrators
• Emergency medical services (EMS) providers
• Trauma care device distributors
• Key opinion leaders (KOLs) in trauma and emergency medicine

Databases

• World Health Organization
• Centers for Disease Control and Prevention
• National Institutes of Health
• U.S. Food and Drug Administration
• Organisation for Economic Co-operation and Development

Magazines

• EMS World
• Trauma System News
• Emergency Medicine News
• Journal of Emergency Medical Services (JEMS)

Journals

• Journal of Trauma and Acute Care Surgery
• Injury
• The Journal of Emergency Medicine
• World Journal of Emergency Surgery
• Military Medicine

Newspapers

• The New York Times
• The Wall Street Journal
• The Guardian
• USA Today

Associations

• American College of Surgeons
• American Trauma Society
• National Association of Emergency Medical Technicians
• International Association for Trauma Surgery and Intensive Care

Public Domain Sources

• Company annual reports and investor presentations
• Government healthcare and defense publications
• Clinical trial registries such as ClinicalTrials.gov
• FDA approval and regulatory databases
• Military healthcare modernization reports

Proprietary Elements

• CMI Data Analytics Tool
• Proprietary CMI Existing Repository of Information for the Last 10 Years